Clinical Study

Determinants of Disability in Multiple Sclerosis: An Immunological and MRI Study

Table 3

Conventional and DT MRI findings from patients with different MS phenotypes.

BMSRRMSSPMS BMS versus RRMS BMS versus SPMS SPMS versus RRMS
LS mean95% CLLS mean95% CLLS mean95% CL

LV10.64.516.66.8−2.316.028.421.935.0nsnsns
NBV1483.31452.41514.21564.31517.31611.31386.11352.61419.6ns0.0010.003
NCV605.3579.0631.6642.8602.8682.7516.9488.4545.4nsnsns
NGMV759.1726.1792.2809.9759.7860.2644.1608.3679.9ns<0.0010.0001
NWMV724.1706.6741.6754.3727.7781.0742.0723.0761.0nsnsns
Left CST FA0.5050.4860.5240.5360.5060.5650.4550.4340.476ns<0.0010.002
Left CST MD0.7200.6980.7420.7130.6800.7460.7650.7410.789ns<0.001<0.0001
Right CST FA0.4730.4580.4880.4960.4730.5180.4320.4160.448ns<0.0001<0.0001
Right CST MD0.7460.7250.7670.7230.6910.7560.7940.7710.817ns<0.0001<0.0001

Data are reported as least squares (LS) means and 95% confidence limits (CL). Lesion and tissue volumes are expressed in cc, MD is expressed in , and FA is a dimensionless index. Between-group comparison values were corrected with Tukey-Kramer and the following variables were taken as covariates: therapy (dichotomic variable: yes/no), age, and gender.
LV: total brain lesion volume; NBV: normalized brain volume; NCV: normalized cortical grey matter volume; NGMV: normalized grey matter volume; NWMV: normalized white matter volume; CST: corticospinal tract; MD: mean diffusivity; FA: fractional anisotropy; ns: not significant.
See the text for other abbreviations and statistical analysis details.